Related Experiment Video
Updated: Dec 28, 2025
07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.0K
IL-21 Signaling in the Tumor Microenvironment
Ghita Chabab1, Nathalie Bonnefoy1, Virginie Lafont2
1IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.
Advances in Experimental Medicine and Biology
|February 16, 2020
Summary
Interleukin-21 (IL-21) is a key immune regulator produced by T cells and natural killer (NK) cells. Understanding IL-21
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Interleukin-21 (IL-21) is an immunomodulatory cytokine produced by T cells and natural killer (NK) cells.
- IL-21 exhibits diverse roles in both immune and non-immune cells, influencing innate and adaptive immunity.
- The cytokine possesses both stimulatory effects on anti-tumor immunity and pro-inflammatory functions implicated in oncogenesis.
Purpose of the Study:
- To summarize the fundamental characteristics and signaling pathways of IL-21.
- To elucidate the multifaceted roles of IL-21 within various immune system components.
- To review the application of IL-21 in the context of cancer immunotherapies.
Main Methods:
- Literature review and synthesis of existing research on IL-21.
- Analysis of IL-21's molecular characteristics and signaling mechanisms.
- Examination of IL-21's biological functions in immunity and cancer.
Main Results:
- IL-21 modulates both innate and specific immune responses.
- It acts as a potent stimulator of T cell and NK cell-mediated antitumor immunity.
- IL-21 also demonstrates pro-inflammatory activities and is linked to oncogenesis.
Conclusions:
- A comprehensive understanding of IL-21 biology is crucial for optimizing therapeutic strategies targeting this cytokine.
- IL-21's dual role in immunity and cancer necessitates careful consideration in therapeutic development.
- Further research into IL-21's complex functions will enhance its utility in cancer immunotherapy.
Related Concept Videos
02:17The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
01:19Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
01:24T Cell Types and Functions
2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K